![]()
|
|
||||||||
J. Biol. Chem., Vol. 278, Issue 21, 19134-19140, May 23, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||



From the
Transcription and Disease Laboratory, Molecular Biology and Genetics Unit, Jawaharlal Nehru Center for Advanced Scientific Research, Jakkur, Bangalore 560064, India,
Chemistry and Physics of Materials Unit, Jawaharlal Nehru Center for Advanced Scientific Research, Jakkur, Bangalore 560064, India
Histone acetyltransferases (HATs) are a group of enzymes that play a significant role in the regulation of gene expression. These enzymes covalently modify the N-terminal lysine residues of histones by the addition of acetyl groups from acetyl-CoA. Dysfunction of these enzymes is often associated with the manifestation of several diseases, predominantly cancer. Here we report that anacardic acid from cashew nut shell liquid is a potent inhibitor of p300 and p300/CBP-associated factor histone acetyltranferase activities. Although it does not affect DNA transcription, HAT-dependent transcription from a chromatin template was strongly inhibited by anacardic acid. Furthermore, we describe the design and synthesis of an amide derivative N-(4-chloro-3-trifluoromethyl-phenyl)-2-ethoxy-6-pentadecyl-benzamide (CTPB) using anacardic acid as a synthon, which remarkably activates p300 HAT activity but not that of p300/CBP-associated factor. Although CTPB does not affect DNA transcription, it enhances the p300 HAT-dependent transcriptional activation from in vitro assembled chromatin template. However, it has no effect on histone deacetylase activity. These compounds would be useful as biological switching molecules for probing into the role of p300 in transcriptional studies and may also be useful as new chemical entities for the development of anticancer drugs.
Received for publication, February 13, 2003
¶ To whom correspondence should be addressed: Transcription and Disease Laboratory, Molecular Biology and Genetics Unit, Jawaharlal Nehru Center for Advanced Scientific Research, Jakkur, Bangalore 560064, India. Tel.: 0091-80-8462750 (ext. 2257); Fax: 0091-80-8462766; E-mail: tapas{at}jncasr.ac.in.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
L. Cui, J. Miao, T. Furuya, Q. Fan, X. Li, P. K. Rathod, X.-z. Su, and L. Cui Histone Acetyltransferase Inhibitor Anacardic Acid Causes Changes in Global Gene Expression during In Vitro Plasmodium falciparum Development Eukaryot. Cell, July 1, 2008; 7(7): 1200 - 1210. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Sung, M. K. Pandey, K. S. Ahn, T. Yi, M. M. Chaturvedi, M. Liu, and B. B. Aggarwal Anacardic acid (6-nonadecyl salicylic acid), an inhibitor of histone acetyltransferase, suppresses expression of nuclear factor-{kappa}B-regulated gene products involved in cell survival, proliferation, invasion, and inflammation through inhibition of the inhibitory subunit of nuclear factor-{kappa}B{alpha} kinase, leading to potentiation of apoptosis Blood, May 15, 2008; 111(10): 4880 - 4891. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Johnson and R. I. Tapping Microbial Products Stimulate Human Toll-like Receptor 2 Expression through Histone Modification Surrounding a Proximal NF-{kappa}B-binding Site J. Biol. Chem., October 26, 2007; 282(43): 31197 - 31205. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. D. Eliseeva, V. Valkov, M. Jung, and M. O. Jung Characterization of novel inhibitors of histone acetyltransferases Mol. Cancer Ther., September 1, 2007; 6(9): 2391 - 2398. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. T. Smith, M. R. Livingston, A. Mai, P. Filetici, S. F. Queener, and W. J. Sullivan Jr. Quinoline Derivative MC1626, a Putative GCN5 Histone Acetyltransferase (HAT) Inhibitor, Exhibits HAT-Independent Activity against Toxoplasma gondii Antimicrob. Agents Chemother., March 1, 2007; 51(3): 1109 - 1111. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Stimson, M. G. Rowlands, Y. M. Newbatt, N. F. Smith, F. I. Raynaud, P. Rogers, V. Bavetsias, S. Gorsuch, M. Jarman, A. Bannister, et al. Isothiazolones as inhibitors of PCAF and p300 histone acetyltransferase activity Mol. Cancer Ther., October 1, 2005; 4(10): 1521 - 1532. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Grasberger, U. Ringkananont, P. LeFrancois, M. Abramowicz, G. Vassart, and S. Refetoff Thyroid Transcription Factor 1 Rescues PAX8/p300 Synergism Impaired by a Natural PAX8 Paired Domain Mutation with Dominant Negative Activity Mol. Endocrinol., July 1, 2005; 19(7): 1779 - 1791. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Huddleson, N. Ahmad, S. Srinivasan, and J. B Lingrel Induction of KLF2 by Fluid Shear Stress Requires a Novel Promoter Element Activated by a Phosphatidylinositol 3-Kinase-dependent Chromatin-remodeling Pathway J. Biol. Chem., June 17, 2005; 280(24): 23371 - 23379. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Balasubramanyam, R. A. Varier, M. Altaf, V. Swaminathan, N. B. Siddappa, U. Ranga, and T. K. Kundu Curcumin, a Novel p300/CREB-binding Protein-specific Inhibitor of Acetyltransferase, Represses the Acetylation of Histone/Nonhistone Proteins and Histone Acetyltransferase-dependent Chromatin Transcription J. Biol. Chem., December 3, 2004; 279(49): 51163 - 51171. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. DRUESNE, A. PAGNIEZ, C. MAYEUR, M. THOMAS, C. CHERBUY, P.-H. DUEE, P. MARTEL, and C. CHAUMONTET Repetitive Treatments of Colon HT-29 Cells with Diallyl Disulfide Induce a Prolonged Hyperacetylation of Histone H3 K14 Ann. N.Y. Acad. Sci., December 1, 2004; 1030(1): 612 - 621. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Balasubramanyam, M. Altaf, R. A. Varier, V. Swaminathan, A. Ravindran, P. P. Sadhale, and T. K. Kundu Polyisoprenylated Benzophenone, Garcinol, a Natural Histone Acetyltransferase Inhibitor, Represses Chromatin Transcription and Alters Global Gene Expression J. Biol. Chem., August 6, 2004; 279(32): 33716 - 33726. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Cheng, N. Yadav, R. W. King, M. S. Swanson, E. J. Weinstein, and M. T. Bedford Small Molecule Regulators of Protein Arginine Methyltransferases J. Biol. Chem., June 4, 2004; 279(23): 23892 - 23899. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-J. Yang The diverse superfamily of lysine acetyltransferases and their roles in leukemia and other diseases Nucleic Acids Res., February 11, 2004; 32(3): 959 - 976. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |